Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Part D low-income shifts

Executive Summary

UnitedHealth is among a minority of the leading Medicare Part D sponsors that added auto-assigned low-income members for 2009 with a gain of 120,000. Universal American was another, with 145,000 net new Medicaid/Medicare dual-eligibles. Among those who lost low-income members, WellCare reported 252,000 fewer dual-eligible members in 2009, and Humana lost 300,000 dual-eligibles. Overall, CMS had to re-assign nearly 1.2 million low-income beneficiaries to a new Part D sponsoring organization in 2009, which is roughly on par with 2008. But the availability of plans qualified for low-income subsidy beneficiaries is shrinking; in states such as Florida, Arizona and Nevada and in the New England region, there are now only five or fewer plans available, according to an analysis by Avalere Health

You may also be interested in...

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 

Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California

US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts